Custom Pharma Services (CPS)CPS Microsite

Our Custom Pharmaceutical Services (CPS) business serves several ‘innovators’, both Big Pharma and emerging biotech, and a large number of emerging Pharma companies. Within a short span, we have become the largest CPS player from India and a partner-of-choice to innovators, offering top-end technical expertise, tailor-made pharma solutions and a track record of bringing innovations to the market quickly, efficiently and economically.

We offer both speed and flexibility. We have the capability to supply both small-scale clinical trial quantities and commercial-scale requirements. Our end-to-end services and competitive pricing makes a compelling value proposition to our global ‘innovator’ customers.

Niche technology-led acquisitions have made us a one-stop shop for many customers. Our acquisition of Roche's API manufacturing unit in Mexico added the capability to manufacture niche steroidal APIs. The acquisition of the Small Molecule business of Dow Pharma at its Mirfield and Cambridge sites in the UK has further strengthened our portfolio and service offerings for our customers. Now we also offer a pool of chiral technologies, including biocatalysis.

We aim to be the preferred partner for innovator companies by providing a complete range of services that are necessary to take their innovations to the market with greater speed, efficiency and lower capital expenditures.

CPS Overview

  • CPS at a snapshot
  • Key Technologies
  • Product Services
CPS at a snapshot
  • Proven track record over 25+ years
  • One of the largest custom pharma businesses from India
  • Broad client base (many large, mid-sized, emerging
    pharma companies and biotechs)
  • Pre-clinical to commercial supply capabilities
  • Expertise in API and formulation space
Dr. Reddy's Key Technologies
  • High Containment & Cytotoxic Capabilities
  • Chiral Products and Technologies-ChiroTech
  • Steroids
  • PEGylation-PEGtech
  • Dosage
Dr. Reddy's Product Services
  • PIs to support combination development and differentiated formulation development of innovators
    • USDMFs
    • CEPs/EDMFs/JDMFs
  • Ready to use library of OTC, differentiated and combination formulations to support lifecycle management
    • ANDAs
    • Dossiers/European Dossiers